[go: up one dir, main page]

Bozicevich et al., 1946 - Google Patents

A method of conducting the 50 percent hemolysis end point complement-fixation test for parasitic diseases

Bozicevich et al., 1946

Document ID
6722819295013221847
Author
Bozicevich J
Hoyem H
Walston V
Publication year
Publication venue
Public Health Reports (1896-1970)

External Links

Snippet

531 April 12, 1946 not attain this titer it is not satisfactory and the animals should be given further immunization. To prepare the sensitized cells for this titration, the amboceptor dilution desired is made up in 10-cc. amounts and an equal volume of the 2-percent cell suspension …
Continue reading at www.jstor.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Similar Documents

Publication Publication Date Title
Pillemer et al. The properdin system and immunity: III. The zymosan assay of properdin
Salk A simplified procedure for titrating hemagglutinating capacity of influenza-virus and the corresponding antibody
Kahn The Kahn test: a practical guide
Bozicevich et al. A method of conducting the 50 percent hemolysis end point complement-fixation test for parasitic diseases
Svejgaard et al. Complement-fixing platelet iso-antibodies
Sequeira et al. Treponemal haemagglutination test
Klein et al. STUDIES ON THE ANTIGENIC PROPERTIES OF COMPLEMENT: I. Demonstration of Agglutinating Antibodies against Guinea Pig Complement Fixed on Sensitized Sheep Erythrocytes
DE2531176B2 (en) Method for the detection of antibodies to gonorrhea
Hansson et al. Improved technique for detecting Australia antigen by immunoelectroosmophoresis
Mason An ox cell haemolysin test for the diagnosis of infectious mononucleosis
Lapin et al. An improved method for isolating viable human leukocytes from peripheral blood
US4532203A (en) Fluorescent determination of microlymphocytotoxicity
US3426123A (en) Diagnostic test for infectious mononucleosis with aldehyde treated equine erythrocytes
Taylor et al. BLOOD GROUPS IN ENGLAND: I. EXAMINATION OF FAMILY AND UNRELATED MATERIAL
Freiesleben et al. Haemolytic Disease of the Newborn Caused by Anti‐M: The Value of the Direct Conglutination Test
Felix et al. Proposed standard agglutinating sera for typhoid and paratyphoid A and B fevers
LoGrippo et al. Serum globulin dyscrasia: lack of virus neutralizing antibodies in normal serum and hypergammaglobulinemia
Stats Gold Aǵǵlutinated Erythrocytes: Hemolytic Effect of Shakinǵ
Levy Complement levels in mammals.
Mackie et al. A study of non-specific complement-fixation with particular reference to the interaction of normal serum and certain non-antigenic substances
US4426357A (en) Antibody elution reagent kit
Lincicome et al. Antigenic relationships among Trypanosoma lewisi—complex cells*: I. Agglutinins in antisera
US3223484A (en) Diagnostic procedure
Lindblad et al. Transaminase and Transferase Activities in Blood-Plasma of Dogs with Experimentally Produced Hepatitis Contagiosa Canis (HCC)
McDowall et al. Increased sensitivity of tests for the detection of blood group antigens in stains using a low ionic strength medium